Phreesia (NYSE:PHR – Get Rating) had its price target boosted by Guggenheim from $30.00 to $35.00 in a research report released on Thursday morning, The Fly reports. The brokerage currently has a buy rating on the stock.
PHR has been the subject of several other research reports. SVB Leerink increased their price objective on shares of Phreesia from $27.00 to $31.00 and gave the stock a market perform rating in a research report on Thursday. Robert W. Baird decreased their target price on shares of Phreesia from $51.00 to $35.00 and set an outperform rating for the company in a research note on Friday, June 3rd. Raymond James decreased their target price on shares of Phreesia from $45.00 to $34.00 in a research note on Monday, June 6th. Royal Bank of Canada decreased their target price on shares of Phreesia from $29.00 to $20.00 in a research note on Monday, June 6th. Finally, JMP Securities decreased their target price on shares of Phreesia from $50.00 to $34.00 and set a market outperform rating for the company in a research note on Friday, June 3rd. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, Phreesia currently has an average rating of Moderate Buy and a consensus price target of $35.92.
Phreesia Price Performance
Phreesia stock opened at $27.64 on Thursday. Phreesia has a 52-week low of $13.19 and a 52-week high of $76.10. The firm has a fifty day moving average of $24.38 and a 200-day moving average of $24.09. The firm has a market capitalization of $1.44 billion, a P/E ratio of -8.97 and a beta of 0.75. The company has a quick ratio of 4.93, a current ratio of 4.93 and a debt-to-equity ratio of 0.02.
Insider Buying and Selling at Phreesia
Institutional Trading of Phreesia
Large investors have recently modified their holdings of the company. First Horizon Advisors Inc. increased its holdings in shares of Phreesia by 573.7% in the 4th quarter. First Horizon Advisors Inc. now owns 923 shares of the company’s stock worth $38,000 after acquiring an additional 786 shares during the period. Advisor Group Holdings Inc. increased its holdings in shares of Phreesia by 63.4% in the 4th quarter. Advisor Group Holdings Inc. now owns 1,319 shares of the company’s stock worth $55,000 after acquiring an additional 512 shares during the period. Captrust Financial Advisors increased its stake in Phreesia by 154.6% during the 2nd quarter. Captrust Financial Advisors now owns 1,426 shares of the company’s stock valued at $36,000 after buying an additional 866 shares during the period. Assetmark Inc. increased its stake in Phreesia by 42.2% during the 2nd quarter. Assetmark Inc. now owns 1,685 shares of the company’s stock valued at $42,000 after buying an additional 500 shares during the period. Finally, Hardy Reed LLC acquired a new position in Phreesia during the 1st quarter valued at about $65,000. Institutional investors and hedge funds own 89.39% of the company’s stock.
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments.
- Get a free copy of the StockNews.com research report on Phreesia (PHR)
- Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
- When Will the Hangover Finally Be Over for Seagate Technology?
- Are These Green Energy Companies Right For Your Portfolio?
- Does Enphase Energy Have the Juice to Keep Powering Higher?
- The One Hydrogen Fuel Cell Stock To Rule Them All
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.